Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial

Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial

Abstract Background People with severe mental illness (SMI) are two to three times more likely to be overweight and obese than the general population and this is associated with significant morbidity and premature mortality. Although lifestyle interventions can support people with SMI to lose weight...

Full description

Bibliographic Details
Main Authors: Clare Alexandra Whicher, Hermione Clare Price, Peter Phiri, Shanaya Rathod, Katharine Barnard-Kelly, Claire Reidy, Kerensa Thorne, Carolyn Asher, Robert Peveler, Joanne McCarthy, Richard Ian Gregory Holt
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Trials
Subjects:
Schizophrenia
Severe mental illness
Obesity
Overweight
Liraglutide
Feasibility
Online Access:http://link.springer.com/article/10.1186/s13063-019-3689-5

Internet

http://link.springer.com/article/10.1186/s13063-019-3689-5

Similar Items